Profil
Yuji Matsumoto currently works at ILS, Inc., as Director and Nomura Securities Co., Ltd., as Research Analyst.
Postes actifs de Yuji Matsumoto
| Sociétés | Poste | Début |
|---|---|---|
Nomura Securities Co., Ltd.
 Nomura Securities Co., Ltd. Investment Banks/BrokersFinance Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors. | Analyst-Equity | - |
ILS, Inc.
 ILS, Inc. Chemicals: Major DiversifiedProcess Industries ILS, Inc. engages in the development, manufacture and sales of pharmaceutical products by using the technology of peptide synthesis and the extraction and purification of biogenic substances. It also offers functional food ingredients. The company was founded on May 20, 2003 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nomura Securities Co., Ltd.
Nomura Securities Co., Ltd. Investment Banks/BrokersFinance Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors. | Finance |
ILS, Inc.
ILS, Inc. Chemicals: Major DiversifiedProcess Industries ILS, Inc. engages in the development, manufacture and sales of pharmaceutical products by using the technology of peptide synthesis and the extraction and purification of biogenic substances. It also offers functional food ingredients. The company was founded on May 20, 2003 and is headquartered in Tokyo, Japan. | Process Industries |